Volume 27, Number 4—April 2021
Research
Emergence of Burkholderia pseudomallei Sequence Type 562, Northern Australia
Table 2
Characteristic | ST, no. (%) |
Bivariate |
|||
---|---|---|---|---|---|
562, n = 53 | Other, n = 387 | OR (95% CI) | p value | ||
Symptoms for <2 months |
50 (94) |
346 (89) |
1.97 (0.59–10.32) |
0.33 |
|
Localization | |||||
Pulmonary | 40 (75) | 263 (68) | 1.45 (0.73–3.06) | 0.34 | |
Abscess† | |||||
Prostatic | 10 (32) | 33 (15) | 2.73 (1.05–6.73) | 0.02 | |
Hepatic | 1 (2) | 13 (3) | 0.55 (0.01–3.82) | >0.99 | |
Splenic | 2 (4) | 25 (6) | 0.57 (0.063–2.39) | 0.76 | |
Renal | 3 (6) | 9 (2) | 2.51 (0.42–10.49) | 0.17 | |
Skin and/or soft tissue | 3 (6) | 51 (13) | 0.40 (0.08–1.30) | 0.17 | |
Bone or joint | 3 (6) | 28 (7) | 0.77 (0.14–2.64) | >0.99 | |
Central nervous system |
0 |
4 (1) |
NA |
>0.99 |
|
Severity | |||||
Bacteremia¶ | 28 (55) | 233 (61) | 0.79 (0.42–1.49) | 0.45 | |
Septic shock | 12 (23) | 66 (17) | 1.42 (0.64–2.94) | 0.34 | |
Death | 7 (13) | 35 (9) | 1.53 (0.54–3.77) | 0.32 |
*NA, not applicable; OR, odds ratio; ST, sequence type. †Missing data for 1 patient with non-ST562 B. pseudomallei infection. Prostate abscess data is for 31 men with ST562 and 223 men with other STs. ¶Missing data for 2 patients with ST562 and 3 patients with other STs.
Page created: February 17, 2021
Page updated: March 18, 2021
Page reviewed: March 18, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.